Role of fusion of prone FDG-PET and magnetic resonance imaging of the breasts in the evaluation of breast cancer

Breast Journal

Volumn 16, Issue 4, 2010, Pages 369-376

  Moy, Linda ^a   Noz, Marilyn E ^a   Maguire Jr , Gerald Q ^b   Melsaether, Amy ^a   Deans, Abby E ^a   Murphy Walcott, Antoinette D ^a   Ponzo, Fabio ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

Breast cancer; Breast MR; Fusion of breast scans; Prone FDG PET scans of the breast

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BODY POSTURE; BREAST BIOPSY; BREAST CANCER; BREAST TUMOR; CANCER DIAGNOSIS; CANCER SIZE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DOUBLE BLIND PROCEDURE; DRUG UPTAKE; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PROSPECTIVE STUDY; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE;

EID: 77956865328     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2010.00927.x     Document Type: Article

References (35)

1. Smith RA. The evolving role of MRI in the detection and evaluation of breast cancer. N Engl J Med 2007;356:1362-1364
2. Lord SJ, Lei W, Craft P, et al. A systematic review of the effectiveness of magnetic resonance imaging (MRI) as an addition to mammography and ultrasound in screening young women at high risk of breast cancer. Eur J Cancer 2007;43:1905-1917
3. Teifke A, Hlawatsch A, Beier T, et al. Undetected malignancies of the breast: dynamic contrast-enhanced MR imaging at 1.0 T. Radiology 2002;224:881-888
4. Kuhl CK. Current status of breast MR imaging. I. Technical issues. Radiology 2007;244:356-378
5. Kuhl CK. Current status of breast MR imaging. Part 2. Clinical applications. Radiology 2007;244:672-691
6. DeMartini W, Lehman C, Partridge S. Breast MRI for cancer detection and characterization: a review of evidence-based clinical applications. Acad Radiol 2008;15:408-416
7. Lehman CD, Isaacs C, Schnall MD, et al. Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. Radiology 2007; 244:381-388
8. Riedl CC, Ponhold L, Flšry D, et al. Magnetic resonance imaging of the breast improves detection of invasive cancer, preinvasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer. Clin Cancer Res 2007;13:6144-6152
9. Hylton N. Magnetic resonance imaging of the breast: opportunities to improve breast cancer management. J Clin Oncol 2005;23:1678-1684 (Pubitemid 46217460)
10. Lee CH. Problem solving MR imaging of the breast. Radiol Clin North Am 2004;42:919-934
11. Padhani AR. Dynamic contrast-enhanced MRI in clinical oncology: current status and future directions. J Magn Reson Imaging 2002;6:407-422
12. Kinkel K, Hylton NM. Challenges to interpretation of breast MRI. J Magn Reson Imaging 2001;13:821-829
13. Jatoi I, Proschan MA. Randomized trials of breast-conserving therapy versus mastectomy for primary breast cancer: a pooled analysis of updated results. Am J Clin Oncol 2005;28:289-294
14. Avril N, Adler LP. F-18 fluorodeoxyglucose-positron emission tomography imaging for primary breast cancer and loco-regional staging. Radiol Clin North Am 2007;45:645-657
15. Kumar R, Chauhan A, Zhuang H, Chandra P, Schnall M, Alavi A. Standardized uptake values of normal breast tissue with 2- deoxy-2-[F-18]fluoro-D: -glucose positron emission tomography: variations with age, breast density, and menopausal status. Mol Imaging Biol 2006;8:355-362
16. Tatsumi M, Cohade C, Mourtzikos KA, Fishman EK, Wahl RL. Initial experience with FDG-PET / CT in the evaluation of breast cancer. Eur J Nucl Med Mol Imaging 2006;33:254-262
17. Wahl RL. Current status of PET in breast cancer imaging, staging, and therapy. Semin Roentgenol 2001;36:250-260
18. Kumar R, Chauhan A, Zhuang H, Chandra P, Schnall M, Alavi A. Clinicopathologic factors associated with false negative FDG-PET in primary breast cancer. Breast Cancer Res Treat 2006;98:267-274
19. Avril N, Rosé CA, Schelling M, et al. Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations. J Clin Oncol 2000;18:3495-3502
20. Moy L, Noz ME, Maguire GQ Jr, et al. Prone mammoPET acquisition improves the ability to fuse MRI and PET breast scans. Clin Nucl Med 2007;32:194-198
21. Berg WA, Weinberg IN, Narayanan D, et al. High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer. Breast J 2006;12:309-323
22. Freifelder R, Cardi C, Grigoras I, Saffer JR, Karp JS. First results of a dedicated breast PET imager, BPET, using NaI(Tl) curveplate detectors. IEEE Nucl Sci Symp Conf Rec 2001;3:1241-1245
23. Murthy K, Aznar M, Thompson CJ, Loutfi A, Lisbona R, Gagnon JH. Results of preliminary clinical trials of the positron emission mammography system PEM-I: a dedicated breast imaging system producing glucose metabolic images using FDG. J Nucl Med 2000;41:1851-1858
24. Brem RF, Floerke AC, Rapelyea JA, Teal C, Kelly T, Mathur V. Breast-specific gamma imaging as an adjunct imaging modality for the diagnosis of breast cancer. Radiology 2008;247:651-657
25. Moy L, Ponzo F, Noz ME, et al. Improving specificity of breast MRI using prone PET and fused MRI and PET 3D volume datasets. J Nucl Med 2007;48:528-537
26. Hillner BE, Siegel BA, Liu D, et al. Impact of positron emission tomography / computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry. J Clin Oncol 2008;26:2155-2161
27. Noz ME, Maguire GQ Jr, Zeleznik MP, Kramer EL, Mahmoud F, Crafoord J. A versatile functional-anatomic image fusion method for volume data sets. J Med Syst 2001;25: 297-307.
28. Olivecrona L, Crafoord J, Olivecrona H, et al. Acetabular component migration in total hip arthroplasty using CT and a semi-automated program for volume merging. Acta Radiol 2002;43:517-527
29. Gorniak RJT, Kramer EL, Maguire GQ Jr, Noz ME, Schettino CJ, Zeleznik MP. Evaluation of a semi-automatic 3D fusion technique applied to molecular imaging and MRI brain / frame volume data sets. J Med Syst 2003;27:141-156
30. American College of Radiology. ACR BI-RADS-Magnetic Resonance Imaging. In: ACR Breast Imaging Reporting & Data System, Breast Imaging Atlas. Reston, VA: American College of Radiology, 2003.
31. Pichler BJ, Judenhofer MS, Catana C, et al. Performance test of an LSO-APD detector in a 7-T MRI scanner for simultaneous PET / MRI. J Nucl Med 2006;47:639-647
32. Yutani K, Tatsumi M, Uehara T, Nishimura T. Effect of patients' being prone during FDG PET for the diagnosis of breast cancer. AJR Am J Roentgenol 1999;173:1337-1339
33. Goerres G, Michel S, Fehr M, et al. Follow-up of women with breast cancer: comparison between MRI and FDG PET. Eur Radiol 2003;13:1635-1644
34. Brem RF, Petrovitch I, Rapelyea JA, Young H, Teal C, Kelly T. Breast-specific gamma imaging with (99m)Tc-sestamibi and magnetic resonance imaging in the diagnosis of breast cancer-a comparative study. Breast J 2007;13:465-469
35. Imbriaco M, Caprio MG, Limite G, et al. Dual-time-point 18F-FDG PET / CT versus dynamic breast MRI of suspicious breast lesions. AJR Am J Roentgenol 2008;191:1323-1330